ADVIA CENTAUR BRAHMS PROCALCITONIN - COFEPRIS Registration 1406R2019 SSA
Access comprehensive regulatory information for ADVIA CENTAUR BRAHMS PROCALCITONIN (ADVIA CENTAUR BRAHMS PROCALCITONIN) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1406R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on July 19, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ADVIA CENTAUR® BRAHMS PROCALCITONIN ESTÁ INDICADO PARA LA DETERMINACIÓN CUANTITATIVA DE PROCALCITONINA (PCT) EN EL SUERO Y EL PLASMA HUMANOS (EDTA, HEPARINA DE LITIO Y HEPARINA DE SODIO) CON LOS SISTEMAS ADVIA CENTAUR, ADVIA CENTAUR XP Y ADVIA C
THE ADVIA CENTAUR BRAHMS PROCALCITONIN ASSAY IS INDICATED FOR THE QUANTITATIVE DETERMINATION OF PROCALCITONIN (PCT) IN HUMAN SERUM AND PLASMA (EDTA, LITHIUM HEPARIN AND SODIUM HEPARIN) WITH THE ADVIA CENTAUR, ADVIA CENTAUR® XP AND ADVIA C SYSTEMS